BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Molina V, Sampson J, Ferrer J, Díaz A, Ayuso JR, Sánchez-Cabús S, Fuster J, García-Valdecasas JC. Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection. Langenbecks Arch Surg 2017;402:95-104. [PMID: 28012034 DOI: 10.1007/s00423-016-1542-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Franken LC, Schreuder AM, Roos E, van Dieren S, Busch OR, Besselink MG, van Gulik TM. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. Surgery. 2019;165:918-928. [PMID: 30871811 DOI: 10.1016/j.surg.2019.01.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 10.0] [Reference Citation Analysis]
2 Wang A, He Z, Cong P, Qu Y, Hu T, Cai Y, Sun B, Chen H, Fu W, Peng Y. Controlling Nutritional Status (CONUT) Score as a New Indicator of Prognosis in Patients With Hilar Cholangiocarcinoma Is Superior to NLR and PNI: A Single-Center Retrospective Study. Front Oncol 2020;10:593452. [PMID: 33505910 DOI: 10.3389/fonc.2020.593452] [Reference Citation Analysis]
3 Bird N, McKenna A, Dunne D, Francis B, Fenwick S, Poston G, Jones R, Malik H. Role of a pre-operative radiological scoring system in determining resectability for potentially resectable hilar cholangiocarcinoma. Eur J Surg Oncol 2019;45:192-7. [PMID: 30297275 DOI: 10.1016/j.ejso.2018.08.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Watanabe N, Ebata T, Yokoyama Y, Igami T, Mizuno T, Yamaguchi J, Onoe S, Nagino M. Postoperative Pancreatic Fistula in Surgery for Perihilar Cholangiocarcinoma. World J Surg 2019;43:3094-100. [PMID: 31407095 DOI: 10.1007/s00268-019-05127-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Chen KJ, Yang FC, Qin YS, Jin J, Zheng SS. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 2018;17:155-162. [PMID: 29636302 DOI: 10.1016/j.hbpd.2018.03.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Ware MJ, Nguyen LP, Law JJ, Krzykawska-Serda M, Taylor KM, Cao HST, Anderson AO, Pulikkathara M, Newton JM, Ho JC, Hwang R, Rajapakshe K, Coarfa C, Huang S, Edwards D, Curley SA, Corr SJ. A new mild hyperthermia device to treat vascular involvement in cancer surgery. Sci Rep 2017;7:11299. [PMID: 28900126 DOI: 10.1038/s41598-017-10508-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
7 Angelico R, Sensi B, Parente A, Siragusa L, Gazia C, Tisone G, Manzia TM. Vascular Involvements in Cholangiocarcinoma: Tips and Tricks. Cancers (Basel) 2021;13:3735. [PMID: 34359635 DOI: 10.3390/cancers13153735] [Reference Citation Analysis]
8 Matsukuma S, Tokumitsu Y, Shindo Y, Matsui H, Nagano H. Essential updates to the surgical treatment of biliary tract cancer. Ann Gastroenterol Surg 2019;3:378-89. [PMID: 31346577 DOI: 10.1002/ags3.12266] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
9 Peng D, Lu J, Hu H, Li B, Ye X, Cheng N. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma. J Gastrointest Surg. 2020;24:330-340. [PMID: 30671792 DOI: 10.1007/s11605-018-04086-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
10 Qin H, Hu X, Zhang J, Dai H, He Y, Zhao Z, Yang J, Xu Z, Hu X, Chen Z. Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection. Liver Int 2021;41:837-50. [PMID: 33306240 DOI: 10.1111/liv.14763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Dondossola D, Ghidini M, Grossi F, Rossi G, Foschi D. Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma. World J Gastroenterol 2020; 26(25): 3542-3561 [PMID: 32742125 DOI: 10.3748/wjg.v26.i25.3542] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Li B, Lu J, Peng DZ, Zhang XY, You Z. Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma. Medicine (Baltimore) 2020;99:e19400. [PMID: 32195935 DOI: 10.1097/MD.0000000000019400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Peng DZ, Lu J, Li B, Hu HJ, Ye XW, Xiong XZ, Cheng NS. A simple scoring system to predict early recurrence of Bismuth-Corlette type IV perihilar cholangiocarcinoma. Gastroenterol Rep (Oxf) 2019;7:345-53. [PMID: 31687154 DOI: 10.1093/gastro/goz012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Li B, You Z, Xiong XZ, Zhou Y, Wu SJ, Zhou RX, Lu J, Cheng NS. Elevated red blood cell distribution width predicts poor prognosis in hilar cholangiocarcinoma. Oncotarget 2017;8:109468-77. [PMID: 29312621 DOI: 10.18632/oncotarget.22694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhou Q, Guan Y, Mao L, Zhu Y, Chen J, Shi J, Tang M, Qiu Y, Zhu B, He J. Modification and establishment of CT criteria in preoperative assessment of portal venous invasion by hilar cholangiocarcinoma. HPB 2018;20:1163-71. [DOI: 10.1016/j.hpb.2018.05.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]